Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Cancers|October 27, 2019
Clinical Challenges and Consequences of Measurable Residual Disease in Non-APL Acute Myeloid LeukemiaMadlen Jentzsch, Sebastian Schwind, Enrica Bach, et al.
Current Treatment Options in Oncology|February 1, 2020
Use of Minimal Residual Disease in Acute Myeloid Leukemia TherapySebastian Schwind, Madlen Jentzsch, Enrica Bach, et al.
Clinical Case Reports|August 17, 2021
Two rare cases of bronchus-associated lymphoid tissue lymphoma successfully treated with rituximab-bendamustineNydia Panitz, Kristin Gerhardt, Cornelia Becker, et al.
Experimental Hematology|June 1, 2014
Elucidating functional heterogeneity in hematopoietic progenitor cells: a combined experimental and modeling approachEnrica Bach, Thomas Zerjatke, Manuela Herklotz, et al.
Oncotargets and Therapy|July 10, 2013
Pretreatment long interspersed element (LINE)-1 methylation levels, not early hypomethylation under treatment, predict hematological response to azacitidine in elderly patients with acute myeloid leukemiaMichael Cross, Enrica Bach, Thao Tran, et al.
Leukemia & Lymphoma|March 17, 2012
Delayed processing of bone marrow samples reveals a prognostic pattern of NME mRNA expression in cytogenetically normal acute myeloid leukemiaEnrica Bach, Rainer Krahl, Thoralf Lange, et al.
Leukemia & Lymphoma|January 19, 2012
Bcr-Abl dependent post-transcriptional activation of NME2 expression is a specific and common feature of chronic myeloid leukemiaSabine Tschiedel, Enrica Bach, Annette Jilo, et al.
Transfusion Medicine (Oxford, England)|June 10, 2025
Extracorporeal photopheresis-New insights into an old procedureSabine Seiffert, Janine Kirchberg, Enrica Bach, et al.
Transfusion|December 11, 2021
Stem-cell mobilization of healthy sibling donors with pegfilgrastim-A prospective open-label phase II trial (EudraCT no: 2005-004971-39)Vladan Vucinic, Madlen Jentzsch, Sabine Leiblein, et al.
Frontiers in Oncology|October 12, 2020
Case Report: Allogeneic Stem Cell Transplantation Following Induction With CPX-351 in Patients With Acute Myeloid Leukemia Is FeasibleVladan Vucinic, Madlen Jentzsch, Sebastian Schwind, et al.
Pageof 3